AFP and neoplasm: While several of these factors have been identified as prognostic factors in other studies (elevated AFP,9, 23 tumor size,11, 21, 23, 24 SBRT dose,8, 10, 11, 25 advanced stage6, 26), low facility case volume and increased time interval from diagnosis to receiving SBRT are new and may warrant further study.